5 Best Stocks to Buy for a Quick Return
Grove Collaborative Holdings, Inc. (NYSE:GROV) announced in March 2023 that it has partnered up with Drew Barrymore to launch two new product lineups.
Kala Pharmaceuticals Inc. (KALA)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Baker Bros. Advisors Julian Baker And Felix Baker | 76,813 | $1,156,036 | 0% | |
| 2. | Samsara BioCapital Srini Akkaraju And Michael Dybbs | 12,024 | $180,961 | 0.03% | |
| 3. | Millennium Management Israel Englander | 143,455 | $2,159 | +90% | 0% |
| 4. | Samsara BioCapital Srini Akkaraju And Michael Dybbs | 0 | $0 | 0% | |
| 5. | Renaissance Technologies Jim Simons | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $7.60 | 40 | Officer | 42 | 2020-10-22 | Filing | |
| $13.39 | 2 | Officer | 2 | 2020-06-05 | Filing | |
| $5.75 | 10,000 | Officer | 10,000 | 2020-03-16 | Filing | |
| $7.89 | 2,534,854 | Director | 2,534,854 | 2020-03-13 | Filing | |
| $7.89 | 6,337,135 | Large Shareholder, Director | 10,874,613 | 2020-03-13 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $28.55 | 60 | 11,495 | 2023-01-04 | Filing | ||
| $28.54 | 60 | 11,883 | 2023-01-04 | Filing | ||
| $28.53 | 73 | 18,536 | 2023-01-04 | Filing | ||
| $28.54 | 62 | 14,835 | 2023-01-04 | Filing | ||
| $28.54 | 198 | 45,966 | 2023-01-04 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 26,528 | $399,247 | 0% | |
| 2. | 24,000 | $361,200 | 0% | |
| 3. | 21,382 | $321,799 | 0% | |
| 4. | 12,372 | $186,199 | 0% | |
| 5. | 11,379 | $171,251 | 0.01% |
News See All
Were Hedge Funds Right About Kala Pharmaceuticals, Inc. (KALA)?
Last year we predicted the arrival of the first US recession since 2009 and we told in advance that the market will decline by at least 20% in (Recession is Imminent: We Need A Travel Ban NOW).
Is KALA A Good Stock To Buy Now?
Many prominent investors, including Warren Buffett, David Tepper and Stan Druckenmiller, have been cautious regarding the current bull market and missed out as the stock market reached another high in...
Hedge Funds Are Piling Into Kala Pharmaceuticals, Inc. (KALA)
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming).
Did Hedge Funds Make The Right Call On Kala Pharmaceuticals, Inc. (KALA)?
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies.
Hedge Funds Have Never Been This Bullish On Kala Pharmaceuticals, Inc. (KALA)
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first.
Is Kala Pharmaceuticals, Inc. (KALA) A Good Stock To Buy?
Hedge funds are not perfect. They have their bad picks just like everyone else. Facebook, a stock hedge funds have loved dearly, lost nearly 40% of its value at one point in 2018.
RA Capital Management Bets Another $20 Million On Kala Pharmaceuticals Inc.
Joint Filing Agreement by and among the Reporting Persons is incorporated herein by reference to Exhibit 1 to the Schedule 13D filed by the Reporting Persons with the Securities and Exchange Commission...
Hedge Fund and Insider Trading News: Larry Robbins, Starboard Value, Starbucks Co. (SBUX), Kala Pharmaceuticals Inc (KALA), and More
Larry Robbins gives out “gag awards” to the kids he coaches in hockey, but not to employees at Glenview Capital Management.
Billionaire Hedge Funds
